Health ❯Medical Research ❯Clinical Trials

Gene Therapy

Patient Outcomes Base Editing Dystrophic Epidermolysis Bullosa

FDA Approves Zevaskyn Gene Therapy for Healing Large Epidermolysis Bullosa Wounds

VIITAL study results demonstrate durable wound closure with prademagene zamikeracel in patients with recessive dystrophic EB

First Personalized CRISPR Therapy Corrects Rare Genetic Disorder in Infant